Sign in

Filings

Finds words inside filing documents. Searching STANDARD BIOTOOLS INC.'s filings · 48 documents indexed.

10 documents · 24 matches

  1. LAB STANDARD BIOTOOLS INC. 10-K 2026-03-16

    Item 1A. Risk Factors

    tariff on product imports from almost all countries and individualized higher tariffs on certain other countries, including a 145% tariff
    15 matches in this document
  2. LAB STANDARD BIOTOOLS INC. 10-Q 2026-11-03

    tariffs, potential growth opportunities, market growth expectations, the effects of competition, cost structure optimization, acceleration of growth, potential merger and acquisition
    1 match in this document
  3. LAB STANDARD BIOTOOLS INC. 8-K 2026-08-05

    tariffs; challenges inherent in developing, manufacturing, launching, marketing, and selling new products; interruptions or delays in the supply of components
    1 match in this document
  4. LAB STANDARD BIOTOOLS INC. 10-Q 2026-08-05

    tariffs, potential growth opportunities, market growth expectations, the effects of competition, cost structure optimization, acceleration of growth, potential merger and acquisition
    1 match in this document
  5. LAB STANDARD BIOTOOLS INC. 10-Q 2026-05-06

    tariffs, potential growth opportunities, market growth expectations, the effects of competition, cost structure optimization, acceleration of growth, potential merger and acquisition
    1 match in this document
  6. LAB STANDARD BIOTOOLS INC. 8-K 2026-05-05

    tariffs; challenges inherent in developing, manufacturing, launching, marketing, and selling new products; interruptions or delays in the supply of components
    1 match in this document
  7. LAB STANDARD BIOTOOLS INC. 8-K 2026-02-24

    tariffs; challenges inherent in developing, manufacturing, launching, marketing, and selling new products; interruptions or delays in the supply of components
    1 match in this document
  8. LAB STANDARD BIOTOOLS INC. 8-K 2026-01-30

    Item 7.01. Regulation FD Disclosure.

    tariffs; challenges inherent in developing, manufacturing, launching, marketing, and selling new products; interruptions or delays in the supply of components
    1 match in this document
  9. LAB STANDARD BIOTOOLS INC. 8-K 2026-01-30

    tariffs; challenges inherent in developing, manufacturing, launching, marketing, and selling new products; interruptions or delays in the supply of components
    1 match in this document
  10. LAB STANDARD BIOTOOLS INC. 8-K 2026-01-08

    tariffs; challenges inherent in developing, manufacturing, launching, marketing, and selling new products; interruptions or delays in the supply of components
    1 match in this document

Page 1 of 1 · 10 documents